GlassScriptPhysician profile
Kristen E Winters
NPI 1487624979
$3,246.20
in general payments reported to CMS, 2019-2025
22 companies · $553 in 2025
The $553 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $431 · 2021: $305 · 2022: $138 · 2023: $869 · 2024: $628 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,049.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $704.51 | 2019-2025 | Augment Injectable, Fixos, Ortholoc 3di Crosscheck |
| Kerecis Limited | $310.68 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Musculoskeletal Transplant Foundation INC. | $207.64 | 2021 | |
| Davol INC. | $191.04 | 2020 | |
| Horizon Therapeutics Plc | $185.32 | 2019-2020 | |
| Smith+Nephew, INC. | $169.96 | 2019-2025 | Stravix, Grafix, Evos |
| Depuy Synthes Sales INC. | $152.72 | 2024 | Motoband, Minibunion, Motoband Cp |
| Solventum Corporation | $149.99 | 2024 | Prevena Restor Axioform, V.A.C. Veraflo Cleanse Choice |
| Integra Lifesciences Corporation | $139.77 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Zimmer Biomet Holdings, INC. | $122.06 | 2020 | |
| Next Science LLC | $118.39 | 2024 | Surgx, Blastx, Xperience |
| Axogen | $112.45 | 2023 | Avance Nerve Graft |
| Hydrofera LLC | $101.76 | 2023-2025 | Cutimed Sorbact, Hydrofera Blue |
| Medtronic Vascular, INC. | $100.00 | 2020 | |
| Abbvie INC. | $99.55 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $96.97 | 2021 | |
| Osiris Therapeutics INC. | $69.14 | 2019 | |
| Nuo Therapeutics | $66.64 | 2024 | |
| Medtronic, INC. | $63.17 | 2022-2025 | Intellis Adaptivestim |
| Bioventus LLC | $32.43 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Kowa Pharmaceuticals America, INC. | $31.45 | 2023 | Seglentis |
| Baxter Healthcare | $20.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Winters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.